Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
Objective We used the Study of Etanercept And Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA) data set to examine the impact of presence of enthesitis, dactylitis, nail disease and/or psoriasis on treatment response in patients with early psoriatic arthr...
Main Authors: | Atul Deodhar, Arthur Kavanaugh, Dafna D Gladman, Laura C Coates, Vibeke Strand, Philip S Helliwell, Alexis Ogdie, Lyrica X H Liu, Gregory Kricorian, David Collier, Phillip J Mease |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-07-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/8/2/e002366.full |
Similar Items
-
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
by: Helliwell, PS, et al.
Published: (2022) -
Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)
by: Mease, P, et al.
Published: (2018) -
Classification and Outcome Measures for Psoriatic Arthritis
by: Ying Ying Leung, et al.
Published: (2018-09-01) -
Classification and outcome measures for psoriatic arthritis
by: Leung, Y, et al.
Published: (2018) -
Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
by: Alexis Ogdie, et al.
Published: (2023-05-01)